3,4-Methylenedioxy-N-methoxyamphetamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

MDMEO, also known as 3,4-methylenedioxy-N-methoxyamphetamine or as N-methoxy-MDA, is a psychoactive drug of the phenethylamine, amphetamine, and MDxx families.[1][2] It is the N-methoxy derivative of MDA.[1][2]

Other names3,4-Methylenedioxy-N-methoxyamphetamine; MDMEO; MDMEOA; MDMeOA; N-Methoxy-MDA
Routes of
administrationOral[1]
ATC code
  • None
Duration of actionUnknown[1]
Quick facts Clinical data, Other names ...
MDMEO
Clinical data
Other names3,4-Methylenedioxy-N-methoxyamphetamine; MDMEO; MDMEOA; MDMeOA; N-Methoxy-MDA
Routes of
administration		Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 1-(2H-1,3-benzodioxol-5-yl)-N-methoxypropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H15NO3
Molar mass209.245 g·mol−1
3D model (JSmol)
  • CC(NOC)Cc1ccc2OCOc2c1
  • InChI=1S/C11H15NO3/c1-8(12-13-2)5-9-3-4-10-11(6-9)15-7-14-10/h3-4,6,8,12H,5,7H2,1-2H3 checkY
  • Key:MTIKJUJMCMDSGM-UHFFFAOYSA-N checkY
  (verify)
Close

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved, Alexander Shulgin lists MDMEO's dose as greater than 180 mg orally and its duration as unknown.[1][2] It produced few or no effects at tested doses.[1]

Chemistry

Properties

MDMEO may be found as white crystals.[1]

Synthesis

The chemical synthesis of MDMEO has been described.[1]

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]

See also

References

External links

Related Articles

Wikiwand AI